Northland Capital Markets Reiterates Outperform Rating on Zogenix, Inc. (ZGNX) Following FDA Resubmission
Tweet Send to a Friend
Northland Capital Markets analyst Carl Byrnes reiterated an Outperform rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
